Related Experiment Video
Updated: Feb 24, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
[Fortuitous detection of composite heterozygous S/C sickle cell disease]
Asmâa Biaz1, Maroua Neji1, Yousra Ajhoun2
1Service de Biochimie-Toxicologie Hôpital Militaire d'Instruction Mohammed V, Rabat, Maroc.
Abstract:
Composite S/C sickle cell disease accounts for 20%-30% of major sickle cell syndromes. We report a case of fortuitous detection of composite heterozygous S/C sickle cell disease in the context of retinal detachment. The patient had been hospitalized in the Department of Ophthalmology for treatment-resistant decreased visual acuity detected 06 months before. The patient's clinical history was marked by total hip replacement (THR) twelve years before. Our study highlights the wide clinical variability of sickle cell disease underlying the importance of early screening and adapted clinical monitoring of patients at-risk, in order to avoid its evolution toward irreversible organic sequelae such as sickle cell retinopathy.
Related Concept Videos
Multiple Allele Traits
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Test for Homogeneity
Pedigree Analysis
Genetic Lingo

